Goserelin versus leuprolide before hysterectomy for uterine fibroids.
Int J Gynaecol Obstet 2007;
101:178-83. [PMID:
18164303 DOI:
10.1016/j.ijgo.2007.10.020]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2007] [Revised: 10/29/2007] [Accepted: 10/29/2007] [Indexed: 11/21/2022]
Abstract
OBJECTIVE
To compare goserelin and leuprolide given before hysterectomy for symptomatic large fibroid uteri.
METHODS
A randomized study of 66 premenopausal women with fibroid uteri at least 14 weeks of gestation in a gravid uterus. Women were randomized to receive either subcutaneous depot 3.6 mg goserelin or 3.75 mg leuprolide every 4 weeks for a total of 3 doses. Hysterectomy was performed within 1 month of the last dose.
RESULTS
A total of 34 women randomized to the goserelin group and 31 women to the leuprolide group were available for analysis. Preoperative hemoglobin level (P=0.89), operative blood loss (P=0.72), and operating time (P=0.39) were not different between the 2 groups. Postoperative hemoglobin was higher in the leuprolide group (P=0.003), but blood transfusion requirement was not different between the groups (P=1.0). Other outcomes and side effects of the drugs were similar.
CONCLUSIONS
Goserelin and leuprolide administered before hysterectomy for uterine fibroids have similar perioperative outcomes.
Collapse